Ben WMHB makes a very valid point when he said…
“Shareholders have been screaming for revenue from Imugene, but it’s worth remembering that for Kite and Juno it was not revenue, but simply a sniff of an FDA approval for their Car T’s, that brought Big Pharma to the table”.
I understand the frustration out there but unfortunately it may get worse before it gets better. All we can do is keep your eyes on the prize.
Good luck holders.
No advice, Imo, dyor
Where is Ben?, page-24
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
-0.002(4.00%) |
Mkt cap ! $356.9M | |||
| Open | High | Low | Value | Volume |
| 5.0¢ | 5.0¢ | 4.7¢ | $2.298M | 47.86M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1925982 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 3452098 | 12 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |